Explore FIGS stock analysis with latest price, earnings, technicals, and forecast. Is FIGS stock a buy? Get balanced insights on valuation and risks for investors.
Introduction
FIGS stock draws attention from investors seeking growth in niche apparel.
The company designs and sells scrubs, lab coats, and lifestyle gear for healthcare workers via its online platform.
Recent strong earnings have boosted FIGS stock price amid a volatile market for consumer stocks.
Latest Stock Price & Trend
FIGS stock closed at $15.27 on February 27, 2026, after surging 18.1% that day on blowout Q4 results.
Year-to-date, it gained sharply, with a 35.52% rise over the past year from lows around $3.57.
The 52-week range spans $3.57 low to recent highs near $15.63, showing a bullish rebound from early 2025 lows.
One-month trend up 19.83%, six-month strong recovery, signaling renewed investor interest post-earnings.
This upward momentum suggests FIGS stock could attract more buyers, but watch for profit-taking.
Technical Analysis
Support levels mark prices where buyers step in, like $13.61 recent low.
Resistance sits near $15.63, a recent high that may cap gains short-term.
RSI at 73 signals overbought conditions, hinting at possible pullback as momentum cools.
MACD shows bullish trend with line above signal, supporting upward pressure.
50-day and 200-day moving averages trend higher, no death cross; volume spiked on earnings rally.
These point to short-term strength but caution on overextension.
Analyst Ratings & Price Targets
Five analysts rate FIGS stock as Hold overall.
Average price target $6.1, but recent updates higher: Keybanc at $17 (Buy upgrade Feb 27, 2026), BTIG and Telsey positive.
Consensus from 12 analysts at $9.88, high $17, low $4.5; implies mixed but improving sentiment.
Wall Street sees potential upside from earnings beat, yet cautious on growth sustainability.
This balanced view helps investors gauge professional expectations.
Insider Activity
Recent insider selling totaled 72.18K shares worth $501.45K over last 30 days, no buys reported.
No large buys signal caution, though common after stock rallies.
Management trends lean toward selling at highs, implying profit-taking over deep concern.
Watch for shifts; selling alone doesn’t spell trouble in rising stocks.
Valuation Analysis
Trailing P/E stands at 181-196x, forward lower with expected EPS growth to $0.07.
Price-to-Sales 1.3-3.32x, EV/Sales 1.72x; revenue hit $569.58M TTM, up 1.82% YoY.
EPS TTM $0.04, free cash flow positive; debt low, cash strong with quick ratio 2.93.
Compares high to peers like broader apparel, but niche justifies premium vs. generic firms.
FIGS stock appears fairly valued on growth, not deeply undervalued.
Recent Earnings & Catalysts
Q4 2025 revenue soared 33% to $201.9M, beating $165.8M estimates; drove 18% stock jump.
Full-year 2024 revenue $555.56M, net income $2.72M; Q3 2025 $152.64M up 5.8%.
EPS beat expectations, guidance positive with 600% EPS growth forecast.
Catalysts include brand loyalty in $12B market, DTC expansion; no major partnerships noted.
Earnings fueled rally, reinforcing direct-sales model strength.
Bullish Case
FIGS taps growing demand for premium healthcare apparel.
Revenue catalysts from market share gains, high 72% gross margins historically.
Tech edge in DTC platform, loyal fans boost repeat buys.
Operational scale supports sustained growth in underserved niche.
Bearish Case
Competition rises in apparel, risking market saturation.
Slowing YoY revenue growth at 1.82% raises flags.
Margin pressures from costs, high P/E vulnerable to misses.
Economic slowdowns hit discretionary healthcare spend.
Market Sentiment & Investor Psychology
Short interest data limited, but options show call buying post-earnings.
Institutional ownership steady; retail chased rally.
Optimistic bias from momentum, value players wary of valuation.
Overall sentiment leans optimistic after Q4 beat.
Short-Term Outlook
Technicals show overbought RSI, high volume on rally.
Momentum favors upside, but resistance at $15.63 looms.
Expect volatility; consolidation likely next weeks.
Medium to Long-Term Outlook
Strong DTC model fits expanding healthcare apparel market.
Financial health solid with cash buffers.
Competitive moat from brand, but watch growth pace.
Long-term investors should hold or watch for dips to accumulate.
FAQ Section
Is FIGS stock a buy right now?
Hold rating prevails, but recent upgrades suggest buy on pullbacks.
What is the price target for FIGS stock?
Average $9.88, high $17 from Keybanc.
What are major risks for FIGS stock?
Competition, slowing growth, high valuation.
FIGS stock forecast?
Mixed; EPS growth potential but cautious targets.
FIGS technical analysis?
Bullish MACD, overbought RSI.
Suggestions
- Compare with Opendoor
- See our [Microsoft stock forecast] for tech parallels
- Read our [tech apparel sector valuation breakdown]
Final Balanced Conclusion
Hold FIGS stock for now.
Strong earnings lift it, but high valuation and insider sales warrant caution; growth intact long-term.
Disclaimer: This article is for informational purposes only and not financial advice.